Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and the funding-status notice and Revision: v3.4.1 were removed; these are administrative and do not affect the study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedNotice added at the top of the page informing users about a lapse in government funding and the NIH Clinical Center's operating status, and the page version updated from v3.4.0 to v3.4.1. These updates do not alter the study details, objectives, eligibility, outcomes, or schedules.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option in the header and updated capitalization for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; introduced a new revision note 'Revision: v3.4.0' to reflect the version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study details or page behavior.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded study locations: New York and Texas. Last Update Posted (Estimated) date was updated.SummaryDifference0.7%

- Check91 days agoChange DetectedThe page revision label changes from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.